Slide 1: H1 2026 Results Presentation
• H1 2026 RESULTS PRESENTATION • August 6th, 2026
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary H1 2026 key trends and figures H1 2026 Sales at €215m, +3.3% organic growth vs. H1 2025 €55.4m adjusted EBITDA in H1 2026, +2.2% YoY, with 25.
Slide 3: H1 2026 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2026 Results At-a-Glance Organic revenue growth and EBITDA % expansion continue in H1 2026 SALES Adjusted EBITDA and % Net Financial Position and Leverage €m
Slide 4: Sales – H1 2026 vs. H1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – H1 2026 vs. H1 2025 +3.3% YoY organic growth, supported by volume and pricing SALES – H1 2025 TO H1 2026 BRIDGE €m • +3.3% growth excl. FX vs. H1 215.6
Slide 5: Sales Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – H1 2026 Performance by Division Transfusion Medicine and Safety leading the growth Healthcare & Life Sciences Safety Energy & Mobility €m €m €m Excl. FX
Slide 6: Adj. EBITDA – H1 2026 vs. H1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. EBITDA – H1 2026 vs. H1 2025 62 bps of margin expansion, supported by pricing ADJ. EBITDA – H1 2025 TO H1 2026 BRIDGE €m 25.1% ADJUSTED EBITDA % 25.7% 62 b
Slide 7: Adj. Net Income – H1 2026 vs. H1 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. Net Income – H1 2026 vs. H1 2025 11.1% margin excl. FX impact vs. 10.2% in Q1 2026 Adj. Net Income Adj. Net Income Excl. FX Gains/Losses €m €m 26.2 -9.1% 2
Slide 8: Net Financial Position – H1 2026 vs. FY 2025
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Net Financial Position – H1 2026 vs. FY 2025 Stable NFP vs. December 2025 mostly linked to NWC seasonality NET FINANCIAL POSITION – FY 2025 TO H1 2026 BRIDGE €m
Slide 9: FY 2026 – Strategic Focus and Guidance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx FY 2026 – Strategic Focus and Guidance FY 2026 guidance confirmed. New business plan on Sep 24th • MedTech: Establish new subdivisions to sharpen commercial foc
Slide 10: H1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2026 Results – Financial Statements H1 2025 and H1 2026 P&L – Statutory Adjusted View of which H1 2025 of which H1 2026 €m H1 2025 % H1 2026 % non-recurring
Slide 11: H1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2026 Results – Financial Statements Reclassified Balance Sheet - FY 2025 – H1 2026 As of As of €m 31-Dec-2025 30-Jun-2026 Net intangible fixed assets 434.3 4
Slide 12: H1 2026 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2026 Results – Financial Statements Cash Flow Statement – H1 2025 – H1 2026 €m H1 2025 H1 2026 Pre-tax result 1.4 31.8 Amortisation, depreciation and writedo
Slide 13: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate